A carregar...
Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety
BACKGROUND: Chronic migraine is associated with significant headache-related disability and psychiatric comorbidity. OnabotulinumtoxinA (BOTOX(®)) is effective and well tolerated in the prophylactic treatment of chronic migraine. This study aimed to provide preliminary data on the efficacy and safet...
Na minha lista:
Publicado no: | Int J Gen Med |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4340374/ https://ncbi.nlm.nih.gov/pubmed/25733924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S70456 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|